| Previous Close | 50.50 |
|---|---|
| Volume | 268,389 |
| Day's Range | 50.09 - 50.76 |
| 52-Week Range | 35.29 - 50.90 |
| Year-to-Date Return | 14.84% |
|---|---|
| 1-Year Return | 32.83% |
| 3-Year Annualized Return | -1.81% |
| 5-Year Annualized Return | 3.22% |
| Expense Ratio | 0.48 |
|---|---|
| Net Assets | $ 440 mil |
| Alpha | 0.08 |
| R-Squared | 0.68 |
| Dividend (Yield) | $0.72 (2.19%) |
| Avg. Market Cap | $ 68,538 mil |
| Beta | 0.67 |
| Price/Earnings | 17.54 |
| Ex-Dividend Date | 6/22/2009 |
| Turnover | 8.00 |
| Standard Deviation | 4.57 |
| Price/Book | 4.77 |
| Management Company | Barclays Global Fund Advisors |
| Administrator | Barclays Global Fund Advisors |
| Company of Name | % of Total | # of Shares Held |
|---|---|---|
| 1. Johnson & Johnson | 8.39% | 613,824 |
| 2. Novartis AG | 6.61% | 588,984 |
| 3. Roche Holding AG | 5.68% | 156,584 |
| 4. Pfizer | 5.59% | 1,503,096 |
| 5. GlaxoSmithKline PLC | 5.10% | 1,154,968 |
| 6. Sanofi-Aventis SA | 3.93% | 238,648 |
| 7. Abbott Laboratories | 3.82% | 344,264 |
| 8. Merck & Co Inc | 3.34% | 469,752 |
| 9. AstraZeneca PLC | 3.25% | 322,184 |
| 10. Wyeth | 3.24% | 296,976 |
| % of Total Holdings | 48.95% |